Voice disorder as a symptom of amyotrophic lateral sclerosis

Česká verzia

Authors: Jana Krtičková ¹; Pavlína Hemerková ²; Jana Šatanková ¹; Jakub Dršata ¹; Viktor Chrobok ¹
Authors place of work: Klinika otorinolaryngologie a chirurgie hlavy a krku, LF UK a FN Hradec Králové ¹; Neurologická klinika LF UK a FN Hradec Králové ²
Published in the journal: Geriatrie a Gerontologie 2021, 10, č. 2: 101-105
Category:

Summary

Voice disorders in elderly are relatively common, patients suffer from dysphonia due to physiologic aging or disease processes associated with aging, including serious neurological disease. Therefore, any changes in the voice should be taken into consideration and laryngologically examined. The aim of this article is to present a dysphonic patient with incomplete vocal cord paralysis, subsequent neurological examination showed amyotrophic lateral sclerosis.

Keywords:

dysphonia – presbyphonia – vocal fold paralysis – motor neuron disease – Amyotrophic lateral sclerosis – bulbar involvement

Zdroje

Ambler Z. Amyotrofická laterální skleróza. Neurol pro Praxi 2006; 1: 9–12.
Bhandari R, Kuhad A, Kuhad A. Edaravone: a new hope for deadly amyotrophic lateral sclerosis. Drugs Today (Barc) 2018; 54(6): 349–360.
Bigliardi G, Malaguti MC, Sola P, et al. Bilateral vocal cord paralysis: a rare onset of amyotrophic lateral sclerosis. Arch Neurol 2010; 67(7): 897–898.
Bradley JP, Hapner E, Johns MM. What is the optimal treatment for presbyphonia? Laryngoscope 2014; 124(11): 2439–2440.
Davids T, Klein AM, Johns MM. Current dysphonia trends in patients over the age of 65: is vocal atrophy becoming more prevalent? Laryngoscope 2012; 122(2): 332–335.
de Carvalho M, Dengler R, Eisen A, et al. Electrodiagnostic criteria for diagnosis of ALS. Clin Neurophysiol 2008; 119(3): 497–503.
Dršata J, et al. Foniatrie – hlas. Havlíčkův Brod: Tobiáš 2011.
Fukae J, Kubo S, Hattori N, et al. Hoarseness due to bilateral vocal cord paralysis as an initial manifestation of familial amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 2005; 6(2): 122–124.
Hillel A, Dray T, Miller R, et al. Presentation of ALS to the otolaryngologist/head and neck surgeon: getting to the neurologist. Neurology 1999; 53(8 Suppl 5): S22–25.
Chang YD, Davis MP, Smith J, et al: Pseudobulbar affect or depression in dementia? J Pain Symptom Manage 2016; 51(5): 954–958.
Lansita JA, Mease KM, QiuH, et al. Nonclinical Development of ANX005: a humanized Anti-C1q antibody for treatment of autoimmune and neurodegenerative diseases. Int J Toxicol 2017; 36(6): 449–462.
Lejska M. Poruchy verbální komunikace a foniatrie. Brno: Paido 2003.
Matejička P, Gažiová M, Minár M, et al. Faktory ovplyvňujúce včasnosť diagnostiky amyotrofickej laterálnej sklerózy. Cesk Slov Neurol N 2018; 81(3): 353–357.
Matoušek P, Zeleník K, Menšíková A, et al. Náhle vzniklá dušnost jako příznak vedoucí k diagnóze amyotrofické laterální sklerózy – kazuistika. Cesk Slov Neurol N 2011; 74/107(2): 215–218.
Miller T, Cudkowicz M, Shaw PJ, et al. Phase 1-2 Trial of antisense oligonucleotide tofersen for SOD1 ALS. N Engl J Med 2020; 383(2): 109–119.
Niedermeyer S, Murn M, Cho PJ. Respiratory failure in amyotrophic lateral sclerosis. Chest 2019; 155(2): 401–408.
Rapoport SK, Menier J, Grant N. Voice changes in the elderly. Otolaryngol Clin North Am 2018; 51(4): 759–768.
Rosenthal LH, Benninger MS, Deeb RH. Vocal fold immobility: a longitudinal analysis of etiology over 20 years. Laryngoscope 2007; 117(10): 1864–1870.
Rosow DE, Pan Dr. Presbyphonia and minimal glottic insufficiency. Otolaryngol Clin North Am 2019; 52(4): 617–625.
Štětkářová I, Matěj R, Ehler E. Nové poznatky v diagnostice a léčbě amyotrofické laterální sklerózy. Cesk Slov Neurol 2018; 81(5): 546–554.
Takano S, Kimura M, Nito T, et al. Clinical analysis of presbylarynx - vocal fold atrophy in elderly individuals. Auris Nasus Larynx 2010; 37(4): 461–464.
Tomik J, Tomik B, Partyka D, et al. A Profile of laryngological abnormalities in patients with amyotrophic lateral sclerosis. J Laryngol Otol 2007; 121(11): 1064–1069.
van der Graaff MM, Grolman W, Westermann EJ, et al. Vocal cord dysfunction in amyotrophic lateral sclerosis: four cases and a review of the literature. Arch Neurol 2009; 66(11): 1329–1333.
Vlčková E. Amyotrofická laterální skleróza. Neurol praxi 2016; 17(6): 362–365.
Watts CR, Vanryckeghem M. Laryngeal dysfunction in amyotrophic lateral sclerosis: a review and case report. BMC Ear Nose Throat Disord 2001; 1(1): 1.
Wijesekera LC, Mathers S,Ta lman P, et al. Natural history and clinical features of the flail arm and flail leg ALS variants. Neurology 2009; 72(12): 1087–1094.
Woo P, Casper J, Colton R, et al. Dysphonia in the aging: physiology versus disease. Laryngoscope 1992; 102(2): 139–144.
Woodson, G. Management of neurologic disorders of the larynx. Ann Otol Rhinol Laryngol 2008; 117(5): 317–326.
Work SS, Colamonico JA, Bradley WG, et al. Pseudobulbar affect: an under-recognized and under-treated neurological disorder. Adv Ther 2011; 28(7): 586–601.
Writing Group; Edaravone (MCI-186) ALS 19 Study Group. Safety and efficacy of edaravone in well defined patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled trial. Lancet Neurol 2017 Jul; 16(7): 505–512.